Wockhardt soars 19%, zooms 75% in 1 month; what's driving pharma stock?

Wockhardt recently received USFDA approval for Zaynich (cefepime and zidebactam), a novel intravenous antibiotic for treating complicated urinary tract infections, including pyelonephritis, in adults.

Go to News Site